What is she best known for?
The fields of study she is best known for:
- Bacteria
- Antibiotics
- Gene
The scientist’s investigation covers issues in Klebsiella pneumoniae, Microbiology, Carbapenem, Imipenem and Antibacterial agent.
Her work carried out in the field of Klebsiella pneumoniae brings together such families of science as Gentamicin, Virology, Colistin, Internal medicine and Drug resistance.
Her Microbiology research is multidisciplinary, incorporating elements of Molecular epidemiology, Enterobacteriaceae, Outbreak and Infection control.
While the research belongs to areas of Carbapenem, Andrea Endimiani spends her time largely on the problem of Ertapenem, intersecting her research to questions surrounding Biapenem.
Her research combines Meropenem and Imipenem.
Her research in Meropenem intersects with topics in Antimicrobial, Pharmacology, Thienamycin and Intensive care medicine.
Her most cited work include:
- Carbapenems: Past, Present, and Future (632 citations)
- Carbapenems: Past, Present, and Future (632 citations)
- Carbapenems: Past, Present, and Future (632 citations)
What are the main themes of her work throughout her whole career to date?
Andrea Endimiani mostly deals with Microbiology, Klebsiella pneumoniae, Enterobacteriaceae, Escherichia coli and Cephalosporin.
She interconnects Plasmid and Multilocus sequence typing in the investigation of issues within Microbiology.
The various areas that Andrea Endimiani examines in her Klebsiella pneumoniae study include Antibacterial agent, Virology, Carbapenem, Internal medicine and Drug resistance.
Her research investigates the connection with Carbapenem and areas like Ertapenem which intersect with concerns in Doripenem.
The Drug resistance study combines topics in areas such as Acinetobacter baumannii and Infection control, Intensive care medicine.
Her studies deal with areas such as Veterinary medicine, Proteus mirabilis and Colonization as well as Cephalosporin.
She most often published in these fields:
- Microbiology (82.27%)
- Klebsiella pneumoniae (36.95%)
- Enterobacteriaceae (21.67%)
What were the highlights of her more recent work (between 2018-2021)?
- Microbiology (82.27%)
- Plasmid (18.72%)
- Antibiotic resistance (16.75%)
In recent papers she was focusing on the following fields of study:
Andrea Endimiani mainly focuses on Microbiology, Plasmid, Antibiotic resistance, Escherichia coli and Multilocus sequence typing.
Andrea Endimiani is studying Multiple drug resistance, which is a component of Microbiology.
As a member of one scientific family, Andrea Endimiani mostly works in the field of Antibiotic resistance, focusing on Infection control and, on occasion, Moraxellaceae, Pneumonia, Acinetobacter baumannii, Acinetobacter and Intensive care.
In the field of Escherichia coli, her study on Carbapenemase producing overlaps with subjects such as Transmission and Fish <Actinopterygii>.
Her Multilocus sequence typing study combines topics in areas such as Medical microbiology and Internal medicine.
Andrea Endimiani combines subjects such as Drug resistance, Colistin, Colonization and Cephalosporin with her study of Enterobacteriaceae.
Between 2018 and 2021, her most popular works were:
- Acinetobacter in veterinary medicine, with an emphasis on Acinetobacter baumannii. (23 citations)
- Acinetobacter in Veterinary Medicine with emphasis on A. baumannii (20 citations)
- Shedding of OXA-181 carbapenemase-producing Escherichia coli from companion animals after hospitalisation in Switzerland: an outbreak in 2018. (14 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
